INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

412 studies · page 7 of 18

2015 / Randomized crossover trial

Organic khorasan wheat improved cardiovascular risk markers in acute coronary syndrome patients.

In a randomized crossover trial, 22 acute coronary syndrome patients consumed cereal products made from organic semi-whole khorasan wheat or modern control wheat for eight weeks each. The khorasan intervention significantly lowered total cholesterol by 6.8%, LDL cholesterol by 8.1%, glucose by 8%, and insulin by 24.6% from baseline. It also reduced reactive oxygen species, tumor necrosis factor-alpha, and lipoperoxidation of circulating monocytes and lymphocytes, whereas control wheat produced no significant changes.

Whittaker A, Sofi F, Luisi ML, et al. Nutrients, 2015. PMID 25970146

2015 / Randomized crossover trial

Morning fasting increased subsequent lunch energy intake incompletely and elevated afternoon insulin concentrations compared to eating breakfast in lean adults.

Thirty-five lean men and women participated in a randomized cross-over trial comparing an extended overnight fast to a carbohydrate-rich breakfast (1963 [SD 238] kJ relative to resting metabolic rate) followed by an ad libitum lunch 3 hours later. Lunch intake was higher following extended fasting (by 640 [SD 1042] kJ, P < 0.01), but total intake remained lower than in the breakfast trial (3887 [SD 1326] vs 5213 [SD 1590] kJ, P < 0.001). Afternoon concentrations of peptide tyrosine-tyrosine and leptin were higher after breakfast (both P < 0.05), while insulin was higher after morning fasting (P < 0.01). Acylated and total ghrelin were not suppressed by lunch in the breakfast trial and remained higher than in the fasting trial throughout the afternoon (all P < 0.05), with no differences between trials in afternoon subjective appetite.

Chowdhury EA, Richardson JD, Tsintzas K, et al. Br J Nutr, 2015. PMID 26004166

2015 / Randomized crossover trial

Vinegar consumed before a meal increased muscle glucose uptake in type 2 diabetes.

In a randomized crossover trial, 11 participants with type 2 diabetes consumed vinegar or placebo before a mixed meal on two separate testing days. Vinegar increased forearm muscle glucose uptake (p = 0.0357) and reduced postprandial plasma glucose (p = 0.0279), insulin (p = 0.0457), and triglycerides (p = 0.0439). Non-esterified fatty acids and glycerol concentrations remained unchanged between interventions.

Mitrou P, Petsiou E, Papakonstantinou E, et al. J Diabetes Res, 2015. PMID 26064976

2015 / Experimental animal study and pilot clinical trial

A fasting mimicking diet promoted multi-system regeneration in mice and reduced disease biomarkers.

Cycles of a fasting mimicking diet extended lifespan, stimulated stem cell regeneration upon re-feeding, reduced visceral fat, decreased cancer incidence, and improved cognitive performance in mice. In a pilot clinical trial, three cycles of the fasting mimicking diet decreased risk factors and biomarkers associated with aging, diabetes, cardiovascular disease, and cancer without causing major adverse effects.

Brandhorst S, Choi IY, Wei M, et al. Cell Metab, 2015. PMID 26094889

2015 / Randomized crossover trial

Morning meal consumption induced higher diet-induced thermogenesis than an identical evening meal

In a randomized crossover study of 20 healthy adults aged 20 to 35 years, consuming an identical test meal at 08:00 hours produced significantly higher post-meal resting metabolic rate than at 20:00 hours (1,916 kcal, 95% CI: 1,792 to 2,041 vs 1,756 kcal, 95% CI: 1,648 to 1,863; p < 0.001). The morning meal also resulted in significantly lower area-under-the-curve differences for glucose, log-insulin, and free fatty acids compared with the evening meal.

Bo S, Fadda M, Castiglione A, et al. Int J Obes (Lond), 2015. PMID 26219416

2015 / Randomized crossover trial

Skipping breakfast increased postprandial hyperglycemia and reduced insulin response in type 2 diabetes

A randomized crossover trial in 22 patients with type 2 diabetes evaluated test days with or without breakfast. Skipping breakfast increased 0-180 minute lunch area under the curve for glucose by 36.8%, free fatty acids by 41.1%, and glucagon by 14.8%, while lowering insulin by 17% and intact GLP-1 by 19% (P < 0.0001). Similar worsening of glucose, fatty acids, glucagon, insulin, and GLP-1 occurred after dinner.

Jakubowicz D, Wainstein J, Ahren B, et al. Diabetes Care, 2015. PMID 26220945

2015 / Randomized crossover trial

Black beans reduced postprandial insulin compared with fiber- or antioxidant-matched meals

In a randomized crossover trial, 12 adults with metabolic syndrome consumed three test meals matched for fiber or antioxidant capacity on three occasions with five hours of postprandial monitoring. Insulin was lower after the black bean meal versus the matched meals (p < 0.0001). Plasma antioxidant capacity differed over time (p = 0.002), oxidized LDL showed no difference by meal, and triglycerides and interleukin-6 rose after meals (p < 0.0001).

Reverri EJ, Randolph JM, Steinberg FM, et al. Nutrients, 2015. PMID 26225995

2015 / Randomized crossover trial

A 3-day barley kernel bread intervention improved insulin sensitivity and increased gut hormones in healthy middle-aged adults.

Twenty middle-aged participants consumed either a barley kernel-based bread (BB) or a reference white wheat bread for 3 consecutive days in a randomized crossover design, followed by a standardized breakfast on day 4. Compared to reference bread, 3 days of BB increased fasting plasma GLP-1 by 56%, postprandial plasma GLP-2 by 13%, and postprandial plasma PYY by 18%. BB intervention also increased breath H2 excretion by 363% and fasting serum SCFAs by 18%, while decreasing blood glucose responses by 22% and serum insulin responses by 17%. Insulin sensitivity index (ISIcomposite) was improved by 25% following the BB intervention.

Nilsson AC, Johansson-Boll EV, Björck IM Br J Nutr, 2015. PMID 26259632

2015 / Randomized crossover trial

A single serving of caffeinated coffee impaired postprandial glucose metabolism in overweight men.

A two-part randomized double-blind crossover study in 10 overweight men examined acute glucose and insulin responses over 2 hours following 50 g glucose with instant decaffeinated coffee and caffeine. Varying caffeine alongside decaffeinated coffee elevated postprandial glucose responses (P=0.008), with 2 g and 4 g coffee increasing glycemic excursions. Escalating coffee amounts with fixed 100 mg caffeine showed no effect.

Robertson TM, Clifford MN, Penson S, et al. Br J Nutr, 2015. PMID 26316273

2015 / Randomized crossover trial

Honey, sucrose, and high-fructose corn syrup produced similar metabolic, inflammatory, and lipid effects in glucose-tolerant and -intolerant individuals.

In a randomized crossover trial, 28 glucose-tolerant and 27 impaired-glucose-tolerant individuals consumed 50 g carbohydrate daily from honey, sucrose, or HFCS55 for 2 weeks each, separated by 2- to 4-week washout periods. Glucose, insulin, HOMA-IR, and OGTT iAUC for glucose or insulin did not differ by sweetener treatment. Across all treatments, body weight and systolic blood pressure were unchanged, diastolic blood pressure decreased, and triglyceride concentrations increased significantly. In the impaired glucose tolerance group, high-sensitivity C-reactive protein increased in response to all sugars.

Raatz SK, Johnson LK, Picklo MJ J Nutr, 2015. PMID 26338891

2015 / 3-year randomized, controlled, parallel study

Fenugreek powder supplementation significantly reduced the cumulative incidence of type 2 diabetes in people with prediabetes over 3 years.

A 3-year randomized controlled trial evaluated the efficacy of fenugreek powder (5 g twice daily before meals) compared to controls in 140 adults with prediabetes. By the end of the intervention, the cumulative incidence rate of diabetes was significantly reduced in the fenugreek group, with controls having a 4.2 times higher chance of developing diabetes. The fenugreek group also experienced significant reductions in fasting plasma glucose, postprandial plasma glucose, and LDL cholesterol, alongside a significant increase in serum insulin. In the fenugreek group, diabetes outcome was positively associated with serum insulin and negatively associated with insulin resistance (HOMA IR).

Gaddam A, Galla C, Thummisetti S, et al. J Diabetes Metab Disord, 2015. PMID 26436069

2015 / Randomized controlled trial

Replacing diet beverages with water led to greater weight loss during energy restriction.

Overweight and obese women on a 24-week weight-loss program were randomized to substitute water for diet beverages or continue drinking diet beverages five times weekly after lunch. Among 62 completers, the water group achieved a significantly greater reduction in weight (-8.8 ± 1.9 kg vs -7.6 ± 2.1 kg; p = 0.015), fasting insulin, and 2-hour postprandial glucose. Waist circumference and lipid profiles did not differ between groups over time.

Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2015. PMID 26537940

2015 / Prospective cohort and randomized controlled trial

A machine-learning algorithm predicted personalized postprandial glycemic responses to meals.

Researchers monitored continuous glucose across 46,898 meals in an 800-person cohort and observed high variability in responses to identical foods. A machine-learning model integrating clinical parameters, diet, anthropometrics, physical activity, and gut microbiota predicted personalized glycemic responses, which was validated in 100 participants. A blinded randomized dietary intervention guided by the algorithm significantly reduced postprandial glycemic responses and altered gut microbiota composition.

Zeevi D, Korem T, Zmora N, et al. Cell, 2015. PMID 26590418

2014 / Double-blind randomized controlled trial

In patients with type 2 diabetes, daily resveratrol increased skeletal muscle SIRT1 expression and resting metabolic rate but reduced daily physical activity.

Ten subjects with type 2 diabetes mellitus were randomized to receive 3 g resveratrol or placebo daily for 12 weeks. Compared with placebo, resveratrol significantly increased skeletal muscle SIRT1 expression (2.01 vs. 0.86 AU, p = .016) and the p-AMPK to AMPK ratio (2.04 vs. 0.79 AU, p = .032). Resveratrol also increased the percentage absolute change in resting metabolic rate (8.6 vs. -13.9%, p = .033) and percentage of predicted resting metabolic rate (7.8 vs. -13.9%, p = .013), but caused significant reductions in average daily activity (-38 vs. 43.2%, p = .028) and step counts (-39.5 vs. 11.8%, p = .047).

Goh KP, Lee HY, Lau DP, et al. Int J Sport Nutr Exerc Metab, 2014. PMID 23918588

2014 / Randomized crossover trial (acute and 8-week interventions)

Brown rice blunted postprandial glucose, protected endothelial function, and improved weight and lipids in men with metabolic syndrome.

Researchers evaluated the acute and long-term effects of brown rice (BR) versus white rice (WR) in randomized crossover trials involving men with the metabolic syndrome. In Study 1, postprandial glucose and insulin AUC increases were lower after BR than WR (P=0.041 and P=0.045, respectively), and the decrease in FMD observed 60 min after WR (P=0.037 vs. baseline) was protected after BR. In Study 2 (n=27), 8 weeks of BR consumption decreased weight-based parameters (which returned to baseline after WR), reduced insulin resistance, and lowered total cholesterol and LDL-cholesterol levels.

Shimabukuro M, Higa M, Kinjo R, et al. Br J Nutr, 2014. PMID 23930929

2014 / Randomized open-label crossover trial

Phyllanthus emblica extract showed antiplatelet activity alone and combined with clopidogrel or ecosprin in type II diabetic patients.

A randomized open-label crossover study evaluated 10 type II diabetic patients given single and multiple (10-day) doses of 500 mg Phyllanthus emblica extract, 75 mg clopidogrel, 75 mg ecosprin, or combinations. Statistically significant decreases in platelet aggregation compared to baseline were observed after single and multiple dose administration across all three treatments and combinations. Bleeding and clotting times were prolonged with all treatments compared to baseline, and all treatments were well tolerated.

Fatima N, Pingali U, Muralidhar N Phytomedicine, 2014. PMID 24291054

2014 / Pilot study

In patients with type 2 diabetes, erythritol acutely improved endothelial function and chronically reduced central pulse pressure.

A pilot study evaluated the vascular effects of erythritol in 24 patients with type 2 diabetes mellitus who consumed 36 g/day of erythritol for 4 weeks alongside a single 24 g dose at baseline and final visits. Acute erythritol intake improved endothelial function measured by fingertip peripheral arterial tonometry from 0.52 ± 0.48 to 0.87 ± 0.29 au (P = 0.005). Chronic consumption for 4 weeks decreased central pulse pressure from 47 ± 13 to 41 ± 9 mmHg (P = 0.02) and tended to decrease carotid-femoral pulse wave velocity (P = 0.06).

Flint N, Hamburg NM, Holbrook M, et al. Acta Diabetol, 2014. PMID 24366423

2014 / Randomized controlled trial

Consuming raisins three times daily reduced postprandial glucose, HbA1c, and blood pressure compared with processed snacks.

A 12-week randomized controlled trial compared 3-times-a-day consumption of raisins (n = 31) with processed snacks (n = 15) in men and women. Fasting plasma glucose and body weight did not change significantly within or between groups. At 12 weeks, raisin intake significantly lowered postprandial glucose (-13.1 mg/dL; P = 0.03 vs snacks) and decreased HbA1c (-0.12%; P = 0.036 vs snacks). Raisin intake was also associated with significant reductions in systolic blood pressure at 4, 8, and 12 weeks (-6.0 to 10.2 mmHg; P = 0.015 to 0.001) and significantly greater changes in diastolic blood pressure than snacks (P < 0.05).

Anderson JW, Weiter KM, Christian AL, et al. Postgrad Med, 2014. PMID 24393750

2014 / Randomized crossover trial

Brown rice meals reduced 24-hour glucose and fasting insulin compared to white rice.

In a crossover trial of 15 overweight Asian Indians without diabetes, participants consumed white rice, brown rice, or brown rice with legumes across 5-day periods. The 5-day average daily glucose incremental area under the curve was 19.8% lower on the brown rice diet (P=0.004) and 22.9% lower on the brown rice with legumes diet (P=0.02) compared to white rice. Percentage changes in fasting insulin were also 57% lower for brown rice and 54% lower for brown rice with legumes.

Mohan V, Spiegelman D, Sudha V, et al. Diabetes Technol Ther, 2014. PMID 24447043

2014 / Randomized controlled trial

Ginger supplementation improved glycemic measures and certain lipids in type 2 diabetes.

Seventy patients with type 2 diabetes were randomly assigned to consume 1600 mg of ginger or a wheat flour placebo daily for 12 weeks. Ginger supplementation significantly decreased fasting blood sugar, glycated hemoglobin, circulating insulin, HOMA scores, triglycerides, total cholesterol, CRP, and PGE2 compared to placebo (p < 0.05). HDL, LDL, and TNFα did not differ significantly between groups.

Arablou T, Aryaeian N, Valizadeh M, et al. Int J Food Sci Nutr, 2014. PMID 24490949

2014 / Randomized, double-blind, placebo-controlled trial

Ginger supplementation improved glycemic control and insulin resistance indices in type 2 diabetes

In 88 participants affected by diabetes, daily intake of three 1-gram ginger powder capsules for 8 weeks reduced fasting blood sugar by 10.5% (p=0.003), while placebo showed a 21% increase (p=0.01). Significant differences occurred between groups for median fasting insulin, insulin sensitivity, and HOMA-IR (p<0.005). Although QUICKI increased significantly in both arms, the mean difference was significantly greater in the ginger group.

Mozaffari-Khosravi H, Talaei B, Jalali BA, et al. Complement Ther Med, 2014. PMID 24559810

2014 / Random block feeding study and in vitro experiment

Glycemic index across four potato types was inversely correlated with their polyphenol content, though individual GI values did not differ significantly.

Nine healthy volunteers were fed four cooked potato types (Purple Majesty, Red-Y38, Yukon Gold, Snowden) providing 50 g of available carbohydrate in a random block design to measure blood glucose and insulin responses. Areas under the curve for blood glucose and insulin did not differ significantly among the potatoes, nor did mean GI values (purple: 77.0 ± 9.0; red: 78.0 ± 14.0; yellow: 81.0 ± 16.0; white: 93.0 ± 17.0). However, there was a significant inverse correlation between potato polyphenol content and GI (r = -0.825, p < 0.05). In vitro, polyphenol extracts of red and purple potatoes inhibited rat intestinal alpha-glucosidase by 37.4 ± 2.2% and 28.7 ± 3.2%, respectively.

Ramdath DD, Padhi E, Hawke A, et al. Food Funct, 2014. PMID 24577454

2014 / Randomized crossover trial

Grain sorghum muffins lowered postprandial glucose and insulin responses in healthy men.

A randomized crossover trial in 10 healthy men compared postprandial responses to a grain sorghum muffin versus a whole-wheat control muffin, both providing 50 g of total starch. Consuming the sorghum muffin significantly reduced the incremental area under the curve for glucose by approximately 35%, from 3,863 ± 443 to 2,871 ± 163 mg (∼3 h) dL(-1). Insulin incremental area under the curve was also significantly decreased from 3,029 ± 965 to 1,357 ± 204 μU (∼3 h) L(-1).

Poquette NM, Gu X, Lee SO Food Funct, 2014. PMID 24608948

2014 / Randomized, double-blind, placebo-controlled trial

In patients with type 2 diabetes and lipid abnormalities, green tea extract improved insulin resistance and glucagon-like peptide 1 only within the group.

Ninety-two patients with type 2 diabetes and lipid abnormalities were randomized to take 500 mg green tea extract or cellulose placebo three times daily for 16 weeks; 39 in the intervention arm and 38 controls completed the study. Within-group comparisons showed green tea extract significantly decreased triglycerides and HOMA-IR (from 5.4±3.9 to 3.5±2.0), increased HDL-C, and increased glucagon-like peptide 1. Adiponectin, apolipoprotein A1, and apolipoprotein B100 increased significantly in both arms. However, in between-group comparisons, only a decreasing trend in triglycerides was observed.

Liu CY, Huang CJ, Huang LH, et al. PLoS One, 2014. PMID 24614112